Paul Gregorevic

Effects of leukemia inhibitory factor on rat skeletal muscles are modulated by clenbuterol.

Hyperbaric oxygen increases the contractile function of regenerating rat slow muscles.

Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol.

Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration.

Endurance training adaptations modulate the redox-force relationship of rat isolated slow-twitch skeletal muscles.

Beta2-adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injury.

Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged rats.

The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice.

Changes in contractile activation characteristics of rat fast and slow skeletal muscle fibres during regeneration.

TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4.

Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin.

Transduction of skeletal muscles with common reporter genes can promote muscle fiber degeneration and inflammation.

miR-206 represses hypertrophy of myogenic cells but not muscle fibers via inhibition of HDAC4.

The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass.

Functional β-adrenoceptors are important for early muscle regeneration in mice through effects on myoblast proliferation and differentiation.

Development of novel activin-targeted therapeutics.

Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival.

Evaluation of follistatin as a therapeutic in models of skeletal muscle atrophy associated with denervation and tenotomy.

Using AAV vectors expressing the β2-adrenoceptor or associated Gα proteins to modulate skeletal muscle mass and muscle fibre size.

The TGF-β Signalling Network in Muscle Development, Adaptation and Disease.

Integrated expression analysis of muscle hypertrophy identifies as a negative regulator of muscle mass.

Differential Effects of IL6 and Activin A in the Development of Cancer-Associated Cachexia.

Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in mice.

Disruption of the Class IIa HDAC Corepressor Complex Increases Energy Expenditure and Lipid Oxidation.

Glucose-6-phosphate dehydrogenase contributes to the regulation of glucose uptake in skeletal muscle.

Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction.

Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest.

The Hippo Signaling Pathway in the Regulation of Skeletal Muscle Mass and Function.

Skeletal muscle-specific overexpression of heat shock protein 72 improves skeletal muscle insulin-stimulated glucose uptake but does not alter whole body metabolism.

Generation of MicroRNA-34 Sponges and Tough Decoys for the Heart: Developments and Challenges.

Activin A-Induced Cachectic Wasting Is Attenuated by Systemic Delivery of Its Cognate Propeptide in Male Mice.

Treatment of type 2 diabetes with the designer cytokine IC7Fc.

Intravascular Follistatin gene delivery improves glycemic control in a mouse model of type 2 diabetes.

Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.

TMEPAI/PMEPA1 Is a Positive Regulator of Skeletal Muscle Mass.

Dynamic Changes to the Skeletal Muscle Proteome and Ubiquitinome Induced by the E3 Ligase, ASB2β.

Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.

Integrated Glycoproteomics Identifies a Role of N-Glycosylation and Galectin-1 on Myogenesis and Muscle Development.

Phosphorylation of ERK and dystrophin S3059 protects against inflammation-associated C2C12 myotube atrophy.

The regulation of polyamine pathway proteins in models of skeletal muscle hypertrophy and atrophy: a potential role for mTORC1.

Yap regulates skeletal muscle fatty acid oxidation and adiposity in metabolic disease.

Tissue-specific expression of Cas9 has no impact on whole-body metabolism in four transgenic mouse lines.

Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia.

Bone Morphogenetic Protein 7 Gene Delivery Improves Cardiac Structure and Function in a Murine Model of Diabetic Cardiomyopathy.